Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity

(2011) Sandra Morel et al.   VACCINE

Clinical Features, Diagnosis and Treatment of Narcolepsy

(2010) Imran Ahmed et al.   CLINICS IN CHEST MEDICINE

Elevated Tribbles homolog 2–specific antibody levels in narcolepsy patients

(2010) Vesna Cvetkovic-Lopes et al.   JOURNAL OF CLINICAL INVESTIGATION

Common variants in P2RY11 are associated with narcolepsy

(2010) Birgitte R Kornum et al.   NATURE GENETICS

Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy

(2010) Hyun Hor et al.   NATURE GENETICS

Narcolepsy is strongly associated with the T-cell receptor alpha locus

(2009) Joachim Hallmayer et al.   NATURE GENETICS

MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database

(2009) Michele Pellegrini et al.   VACCINE